news Polymerised oestrogen provides neuroprotection in pre-clinical study 23 March 2021 | By Victoria Rees (Drug Target Review) The polymerised form of oestrogen has shown success in mice at preventing further damage to the spinal cord after injury.
news Researchers modifiy E. coli to produce chondroitin sulphate 3 March 2021 | By Victoria Rees (Drug Target Review) A team has created a biosynthetic pathway for E. coli that allows the bacteria to produce a common arthritis drug.
article Five developments in oncology targets 30 July 2020 | By Hannah Balfour (Drug Target Review) Drug Target Review explores some of the newest oncologic drug targets, including those for glioblastoma, lung cancer and breast cancer.
news Seaweed extract outperforms remdesivir as COVID-19 therapy in vitro 27 July 2020 | By Victoria Rees (Drug Target Review) According to new research, sulfated polysaccharides extracted from seaweed were more effective at inhibiting SARS-CoV-2 infection in mammalian cells than remdesivir.
news Researchers develop imaging technique to study 3D-printed brain tumours 9 March 2020 | By Victoria Rees (Drug Target Review) A new method has been created by researchers to 3D bioprint tumours and image glioblastomas for the study of therapeutics.
news C1 compound identified as promising Alzheimer’s drug candidate 5 February 2020 | By Victoria Rees (Drug Target Review) Researchers have screened thousands of drugs to discover that C1 effectively blocks the production of amyloid fibrils, so could be an effective therapeutic.
news Polymerised oestrogen shown to protect nervous system cells 24 October 2019 | By Victoria Rees (Drug Target Review) Researchers have polymerised oestrogen using a new approach and found it is effective at protecting and regenerating nervous system cells in vitro.
